Literature DB >> 12383196

CD20-mediated apoptosis: signalling through lipid rafts.

Julie P Deans1, Haidong Li, Maria J Polyak.   

Abstract

CD20 is an effective target for therapeutic B-cell depletion with monoclonal antibodies. One proposed mechanism of action is direct cytotoxicity mediated via tyrosine kinase-dependent signalling pathways activated upon CD20 cross-linking. The association of CD20 with membrane microdomains known as lipid rafts, enriched in src-family tyrosine kinases and other signalling effectors, suggests an indirect mechanism of anti-CD20-induced apoptosis in which activation of src-family kinases occurs as a consequence of lipid raft clustering.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12383196      PMCID: PMC1782791          DOI: 10.1046/j.1365-2567.2002.01495.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  67 in total

Review 1.  Clinical applications of anti-CD20 antibodies.

Authors:  A K Gopal; O W Press
Journal:  J Lab Clin Med       Date:  1999-11

2.  Activation of a calcium-permeable cation channel CD20 expressed in Balb/c 3T3 cells by insulin-like growth factor-I.

Authors:  M Kanzaki; L Nie; H Shibata; I Kojima
Journal:  J Biol Chem       Date:  1997-02-21       Impact factor: 5.157

3.  CD20 is physically and functionally coupled to MHC class II and CD40 on human B cell lines.

Authors:  C Léveillé; R AL-Daccak; W Mourad
Journal:  Eur J Immunol       Date:  1999-01       Impact factor: 5.532

4.  Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets.

Authors:  R A Clynes; T L Towers; L G Presta; J V Ravetch
Journal:  Nat Med       Date:  2000-04       Impact factor: 53.440

5.  Fc epsilon RI-mediated recruitment of p53/56lyn to detergent-resistant membrane domains accompanies cellular signaling.

Authors:  K A Field; D Holowka; B Baird
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

6.  Further biochemical studies of the human B-cell differentiation antigens B1 and B2.

Authors:  H C Oettgen; P J Bayard; W Van Ewijk; L M Nadler; C P Terhorst
Journal:  Hybridoma       Date:  1983

7.  Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study.

Authors:  B Coiffier; C Haioun; N Ketterer; A Engert; H Tilly; D Ma; P Johnson; A Lister; M Feuring-Buske; J A Radford; R Capdeville; V Diehl; F Reyes
Journal:  Blood       Date:  1998-09-15       Impact factor: 22.113

8.  The association between CD20 and Src-family Tyrosine kinases requires an additional factor.

Authors:  I J Popoff; J A Savage; J Blake; P Johnson; J P Deans
Journal:  Mol Immunol       Date:  1998-03       Impact factor: 4.407

9.  Mice carrying a CD20 gene disruption.

Authors:  T L O'Keefe; G T Williams; S L Davies; M S Neuberger
Journal:  Immunogenetics       Date:  1998-07       Impact factor: 2.846

10.  Engagement of CD20 suppresses apoptosis in germinal center B cells.

Authors:  M Holder; G Grafton; I MacDonald; M Finney; J Gordon
Journal:  Eur J Immunol       Date:  1995-11       Impact factor: 5.532

View more
  62 in total

1.  The role of cholesterol in UV light B-induced apoptosis.

Authors:  Kimberly S George; Walid Elyassaki; Qiong Wu; Shiyong Wu
Journal:  Photochem Photobiol       Date:  2011-12-16       Impact factor: 3.421

Review 2.  What signals are generated by anti-CD20 antibody therapy?

Authors:  Benjamin Bonavida
Journal:  Curr Hematol Malig Rep       Date:  2006-12       Impact factor: 3.952

Review 3.  Lipid raft: A floating island of death or survival.

Authors:  Kimberly S George; Shiyong Wu
Journal:  Toxicol Appl Pharmacol       Date:  2012-01-24       Impact factor: 4.219

4.  Biological activity of anti-CD20 multivalent HPMA copolymer-Fab' conjugates.

Authors:  Russell N Johnson; Pavla Kopečková; Jindřich Kopeček
Journal:  Biomacromolecules       Date:  2012-02-21       Impact factor: 6.988

5.  Rituxan (anti-CD20 antibody)-induced translocation of CD20 into lipid rafts is crucial for calcium influx and apoptosis.

Authors:  E Janas; R Priest; J I Wilde; J H White; R Malhotra
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

6.  Cholesterol depletion inhibits src family kinase-dependent calcium mobilization and apoptosis induced by rituximab crosslinking.

Authors:  Tammy L Unruh; Haidong Li; Cathlin M Mutch; Neda Shariat; Lana Grigoriou; Ratna Sanyal; Christopher B Brown; Julie P Deans
Journal:  Immunology       Date:  2005-10       Impact factor: 7.397

Review 7.  How does B cell depletion therapy work, and how can it be improved?

Authors:  E A Clark; J A Ledbetter
Journal:  Ann Rheum Dis       Date:  2005-11       Impact factor: 19.103

8.  NK-cell activation and antibody-dependent cellular cytotoxicity induced by rituximab-coated target cells is inhibited by the C3b component of complement.

Authors:  Siao-Yi Wang; Emilian Racila; Ronald P Taylor; George J Weiner
Journal:  Blood       Date:  2007-11-16       Impact factor: 22.113

9.  Disruption of Aneuploidy and Senescence Induced by Aurora Inhibition Promotes Intrinsic Apoptosis in Double Hit or Double Expressor Diffuse Large B-cell Lymphomas.

Authors:  Shariful Islam; Wenqing Qi; Carla Morales; Laurence Cooke; Catherine Spier; Eric Weterings; Daruka Mahadevan
Journal:  Mol Cancer Ther       Date:  2017-06-14       Impact factor: 6.261

Review 10.  Immunotherapy of cancer.

Authors:  Hossein Borghaei; Mitchell R Smith; Kerry S Campbell
Journal:  Eur J Pharmacol       Date:  2009-10-20       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.